StreetInsider.com News Articles

Oracle's Project Jupiter awards nearly $1B in contracts to New Mexico firms

Fri, 23 Oct 2026 10:40:12 -0400

Oracle (NYSE: ORCL) announced construction and contracting milestones for Project Jupiter, a data center development in New Mexico, according to a company press release dated Oct. 23, 2026.

As of Sept. 30, 2026, the project has awarded more than $994 million in contracts to 30 New Mexico-based firms covering services including HVAC, plumbing, electrical, insulation, sanitation, and construction equipment rentals. Of that total, more than $160 million has already been paid to local companies.

The project has employed 1,230 New Mexico residents to date, including 630 from Doña Ana County. A total of 1,846 union workers across various trades have contributed to

ORACLE INVESTOR DAY MEETING TO BE HELD OCTOBER 28, 2026

Fri, 23 Oct 2026 08:06:00 -0400

AUSTIN, Texas, Oct. 23, 2026 /PRNewswire/ -- Oracle (NYSE: ORCL) today announced that it will hold its Investor Day Meeting at Oracle AI World, Wednesday, October 28, 2026. Oracle's Investor Day Meeting will be live at 10:55 a.m. Central Time via the Investor Relations homepage at www.oracle.com/investor.

ORACLE INVESTOR DAY MEETING TO BE HELD OCTOBER 28, 2026

Fri, 23 Oct 2026 08:06:00 -0400

Oracle pledges $1B over four years to expand partner network

Fri, 23 Oct 2026 08:02:13 -0400

Oracle (NYSE: ORCL) announced a $1 billion commitment over four years to its partner ecosystem, aimed at expanding resources for partners developing AI-powered solutions and services for customers.

The investment covers Oracle PartnerNetwork (OPN) benefits and incentives, including training and certification, technical enablement, development and testing environments, cloud migration funding, go-to-market collaboration, and commercialization through Oracle Marketplace. The announcement was made at Oracle AI World in Las Vegas.

Oracle's partner ecosystem includes systems integrators, independent software vendors, cloud and managed service providers, value-added distributors, resellers, and advisory firms. Partners work across Oracle Fusion Applications, Oracle Database, Oracle Cloud Infrastructure, and related AI

Oracle pledges $1B over four years to expand partner network

Fri, 23 Oct 2026 08:02:13 -0400

Oracle (NYSE: ORCL) announced a $1 billion commitment over four years to its partner ecosystem, aimed at expanding resources for partners developing AI-powered solutions and services for customers.

Oracle Announces $1 Billion Investment to Accelerate Partner Growth and AI-Driven Modernization for Customers

Fri, 23 Oct 2026 08:01:00 -0400

Expanded benefits and incentives provide resources to build offerings, pursue new business, and deliver customer success

LAS VEGAS, Oct. 23, 2026 /PRNewswire/ -- Oracle AI World -- Oracle today announced a $1 billion commitment to its partner ecosystem to help partners capitalize on customer demand for AI-powered solutions and services.

Oracle Announces $1 Billion Investment to Accelerate Partner Growth and AI-Driven Modernization for Customers

Fri, 23 Oct 2026 08:01:00 -0400

Expanded benefits and incentives provide resources to build offerings, pursue new business, and deliver customer success

Oracle Expands Marketplace to Unlock New Partner Growth Opportunities

Fri, 23 Oct 2026 08:00:00 -0400

Expanded access to cloud commitments, collaboration with Oracle sellers, and new purchasing options help partners turn enterprise demand into revenue

LAS VEGAS, Oct. 23, 2026 /PRNewswire/ -- Oracle AI World -- Oracle today announced enhancements to Oracle Marketplace designed to help software and services partners, especially independent software vendors (ISVs), grow their businesses with

Oracle Expands Marketplace to Unlock New Partner Growth Opportunities

Fri, 23 Oct 2026 08:00:00 -0400

Expanded access to cloud commitments, collaboration with Oracle sellers, and new purchasing options help partners turn enterprise demand into revenue

Oracle commits $1 billion to partner ecosystem over four years

Fri, 23 Oct 2026 07:54:36 -0400

Oracle announced a $1 billion investment in its partner ecosystem, to be spread over four years, aimed at expanding opportunities for partners to develop solutions and services built around artificial intelligence.

The commitment, announced at Oracle AI World in Las Vegas, targets the Oracle PartnerNetwork (OPN), which includes systems integrators, independent software vendors, cloud and managed service providers, value-added distributors, resellers, and advisory firms.

The investment is planned to cover training and certification, technical enablement, development and testing environments, cloud migration funding, go-to-market collaboration, and commercialization through Oracle Marketplace.

Oracle said the funding is organized across four areas: building differentiated offerings, selling and

Oracle (ORCL) PT Lowered to $206 at Goldman Sachs

Fri, 23 Oct 2026 06:52:02 -0400

Goldman Sachs analyst Gabriela Borges lowered the price target on Oracle (NYSE: ORCL) to $206.00 (from $240.00) while maintaining a Buy rating.

Oracle (ORCL) Reiterated at Overweight by Cantor Fitzgerald - Still Well-Positioned

Thu, 22 Oct 2026 08:09:44 -0400

Cantor Fitzgerald analyst Thomas Blakey reiterated an Overweight rating and $284.00 price target on Oracle (NYSE: ORCL).

The analyst commented, "We continue to view Oracle as well positioned to take advantage of AI demand given its unique data and application/agentic workflow assets combined with an expanding GPU fleet for OCI, and a core view that CSPs will remain integral in diffusing intelligence across the enterprise, supporting our OW rating and $284 PT (21x C28, in-line with one- and three-year median P/E)."

For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click

Southwest General expands Oracle technology across clinical and finance ops

Wed, 21 Oct 2026 08:06:24 -0400

Southwest General Health Center, a 368-bed not-for-profit acute care hospital in Middleburg Heights, Ohio, is expanding its use of Oracle (NYSE: ORCL) technology to integrate clinical, financial, and operational systems across the organization.

Building on its existing use of Oracle Health Foundation EHR and Oracle Health AI Agents, the hospital is adopting Oracle Health Patient Accounting, Oracle Health Data Intelligence, and the full Oracle Fusion Cloud Applications suite, according to a press release from Oracle.

Oracle Health Patient Accounting will consolidate billing, payments, claims, and account information into a single system for Southwest General's revenue cycle team. Oracle Health Data Intelligence will

Oracle launches AI agentic HR applications powered by Fusion Claw

Wed, 21 Oct 2026 08:02:54 -0400

Oracle (NYSE: ORCL) announced new agentic applications for human resources built on its Fusion Claw execution runtime, unveiled at the HR Technology Conference in Las Vegas on Oct. 21, 2026.

Fusion Claw is described as a governed agentic execution runtime integrated into Oracle Fusion Cloud Applications. It is designed to handle complex, longer-running tasks including research, computation, simulation, and continuous replanning, operating within organizational governance controls.

The new applications are available within Oracle Fusion Cloud Human Capital Management (HCM) and span three categories. Workforce Planning and Operations includes Workforce Orchestration and Positions Command Center tools. Talent Acquisition covers Candidate Sourcing and a

Oracle launches AI agentic HR applications powered by Fusion Claw

Wed, 21 Oct 2026 08:02:54 -0400

Oracle (NYSE: ORCL) announced new agentic applications for human resources built on its Fusion Claw execution runtime, unveiled at the HR Technology Conference in Las Vegas on Oct. 21, 2026.

Southwest General Expands Relationship with Oracle to Connect Care, Finance, and Operations

Wed, 21 Oct 2026 08:02:00 -0400

Oracle Health and Oracle Fusion Cloud Applications will help bring data together, streamline work, and support a more connected patient experience

AUSTIN, Texas, Oct. 21, 2026 /PRNewswire/ -- Southwest General, a private, not-for-profit, acute care hospital in Middleburg Heights, Ohio, is expanding its relationship with Oracle. Building on its use of

Southwest General Expands Relationship with Oracle to Connect Care, Finance, and Operations

Wed, 21 Oct 2026 08:02:00 -0400

Oracle Health and Oracle Fusion Cloud Applications will help bring data together, streamline work, and support a more connected patient experience

Oracle Introduces Claw-Powered Fusion Agentic Applications for HR

Wed, 21 Oct 2026 08:00:00 -0400

New Fusion Claw applications help business and HR leaders achieve defined workforce outcomes with greater speed and confidence by continuously adapting and executing complex work with enterprise governance

LAS VEGAS, Oct. 21, 2026 /PRNewswire/ -- HR Technology Conference -- Oracle today announced new Fusion Claw-powered agentic applications for HR. Oracle Fusion Claw is a governed agentic execution runtime that

Oracle Introduces Claw-Powered Fusion Agentic Applications for HR

Wed, 21 Oct 2026 08:00:00 -0400

Oracle announces AI Agent Studio for industry-specific applications

Wed, 21 Oct 2026 07:01:42 -0400

Oracle (NYSE: ORCL) announced Oracle AI Agent Studio for Industry Applications, a no-code and low-code platform for creating, testing, deploying, and managing AI agents tailored to industry-specific business processes, according to a company statement dated Oct. 21, 2026.

The platform builds on Oracle AI Agent Studio for Fusion Applications and is designed to work with Oracle Industry Applications, Oracle Fusion Applications, and Oracle Cloud Infrastructure (OCI). It supports use cases across sectors including engineering and construction, retail, financial services, restaurants, government, utilities, communications, and hospitality.

Key features include prebuilt industry agents and workflow templates, natural-language and visual authoring tools, cross-application orchestration, Model

Oracle announces AI Agent Studio for industry-specific applications

Wed, 21 Oct 2026 07:01:42 -0400

Key features include prebuilt industry agents and workflow templates, natural-language and visual authoring tools, cross-application orchestration, Model

Oracle AI Agent Studio for Industry Applications Helps Accelerate Business Outcomes

Wed, 21 Oct 2026 07:00:00 -0400

New platform enables customers and partners to easily and securely create, extend, deploy, and manage industry-specific AI agents and teams of agents across the enterprise

AUSTIN, Texas, Oct. 21, 2026 /PRNewswire/ -- Oracle today announced Oracle AI Agent Studio¹ for Industry Applications, a no-code and low-code environment for creating, testing, orchestrating, deploying, and managing AI agents and workflows for industry-specific business

Oracle AI Agent Studio for Industry Applications Helps Accelerate Business Outcomes

Wed, 21 Oct 2026 07:00:00 -0400

New platform enables customers and partners to easily and securely create, extend, deploy, and manage industry-specific AI agents and teams of agents across the enterprise

Oracle and AstraZeneca sign agreement to improve clinical trials with AI

Tue, 20 Oct 2026 05:58:01 -0400

Oracle (NYSE: ORCL) and AstraZeneca announced a non-binding agreement to explore how AI and real-world data can be used to identify eligible patients for clinical trials, accelerate evidence generation, and bring research insights into clinical care workflows, according to a press release issued Oct. 20, 2026.

The collaboration plans to combine AstraZeneca's scientific and therapeutic expertise with Oracle's health data, cloud, AI, analytics, and clinical workflow capabilities. Initial disease areas under consideration include oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases.

Patient recruitment, described in the release as one of the largest obstacles in clinical trials, is a

Oracle and AstraZeneca sign agreement to improve clinical trials with AI

Tue, 20 Oct 2026 05:58:01 -0400

Patient recruitment, described in the release as one of the largest obstacles in clinical trials, is a